Product Information
- 3,5,7-Trihydroxy-4'-methoxyl-8-prenylflavone-3-O-rhamnopyranoside
- 3-[(6-Deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside
- Baohuoside 1
- Baohuside I
- Icariin II
- Icariside II
- See more synonyms
Icarisid II is a drug that has been shown to have an effect on postprandial blood glucose levels. It is used as a control method for the prevention and treatment of squamous cell carcinoma. Icarisid II also inhibits the expression of toll-like receptor 4, which plays an important role in maintaining homeostasis in the body and inhibiting tumor growth. Icarisid II was found to be more effective than icariside when combined with baohuoside for treating melanoma cells. Icarisid II may also act as an EGFR inhibitor and apoptosis pathway activator, enhancing its antitumor activity.
Chemical properties
Technical inquiry about: 3D-FI73956 Icarisid II
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
